Sierra Summit Advisors »

Alnylam Pharmaceuticals shares owned by Sierra Summit Advisors

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Sierra Summit Advisors from 13F filings

Historical chart of Sierra Summit Advisors investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Sierra Summit Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Sierra Summit Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $10M 30k 330.87

More positions owned by Sierra Summit Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Tesla Motors (TSLA)
Lumentum Hldgs (LITE)
Eli Lilly & Co. (LLY)
Citigroup Com New (C)
Vertiv Holdings Com Cl A (VRT)
Amazon (AMZN)
Ge Vernova (GEV)
Chevron Corporation (CVX)
Rocket Cos Com Cl A (RKT)
Robinhood Mkts Com Cl A (HOOD)
Meta Platforms Cl A (META)
Deere & Company (DE)

View all positions for Sierra Summit Advisors

Top funds holding Alnylam Pharmaceuticals

FMR
Vanguard Group
Capital World Investors
BlackRock
Capital Research Global Investors
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
Geode Capital Management
Baillie Gifford & Co
Two Sigma Investments
Dodge & Cox
T. Rowe Price Investment Management
Wellington Management Company
American Century Companies

View all funds holding Alnylam Pharmaceuticals